Lydia Capps
Nurse Practitioner · Peru, INNPI 1922666106
Payments from drug & device makers
Across 350 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$529
- AstraZeneca$364
- Bayer$348
- Esperion Therapeutics, Inc.$272
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,50098%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 78 | $1,196 |
| Novo Nordisk | 76 | $1,165 |
| Lilly USA, LLC | 40 | $529 |
| AstraZeneca(2 entities) | 22 | $364 |
| Bayer | 17 | $348 |
| Esperion Therapeutics, Inc. | 16 | $272 |
| Astellas Pharma US Inc | 9 | $197 |
| Amgen(2 entities) | 8 | $175 |
| Biohaven Pharmaceuticals, Inc. | 9 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $128 |
| Merck | 9 | $118 |
| Boehringer Ingelheim | 6 | $116 |
| Mylan Specialty L.p. | 7 | $106 |
| Novartis | 6 | $90 |
| Pfizer | 4 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $57 |
| Exact Sciences | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Ultragenyx Pharmaceutical Inc. | 1 | $49 |
| Biogen | 3 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $43 |
| Sanofi Pasteur Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $32 |
| IBSA Pharma Inc. | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Impel Pharmaceuticals Inc. | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $25 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| GSK | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,600 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 21 | $283 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Peru
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.